Medline Inc. (MDLN) Stock Analysis

Medline is a mission-critical healthcare infrastructure compounder with a powerful brand-conversion flywheel, but near-term upside depends on margin recovery, tariff mitigation, and sponsor overhang absorption.

Overview

Medline is the largest U.S. medical-surgical supply and healthcare logistics provider, combining proprietary manufacturing with large-scale third-party distribution. Its Prime Vendor model makes it mission-critical to hospitals and non-acute care sites, delivering recurring, resilient revenue across healthcare settings. With 190,000 Medline-branded products, 145,000 distributed products, 70 distribution centers, and next-day delivery to 95% of U.S. customers, Medline benefits from scale, reliability, and 98%+ Prime Vendor retention. International markets remain meaningfully underpenetrated, creating a long runway for expansion.

Read the full Medline Inc. research report

Loading the interactive MDLN dashboard…